TransMedics Group Inc (TMDX)
Current ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 497,216 | 492,475 | 509,265 | 488,306 | 510,654 | 536,724 | 662,655 | 261,730 | 252,294 | 250,586 | 95,113 | 105,795 | 118,705 | 125,577 | 135,052 | 140,543 | 146,766 | 154,126 | 158,227 | 91,704 |
Total current liabilities | US$ in thousands | 59,913 | 60,048 | 54,329 | 50,223 | 54,934 | 49,101 | 32,017 | 28,635 | 23,661 | 20,689 | 22,741 | 20,256 | 23,238 | 15,923 | 15,079 | 11,757 | 11,879 | 13,624 | 13,818 | 15,039 |
Current ratio | 8.30 | 8.20 | 9.37 | 9.72 | 9.30 | 10.93 | 20.70 | 9.14 | 10.66 | 12.11 | 4.18 | 5.22 | 5.11 | 7.89 | 8.96 | 11.95 | 12.36 | 11.31 | 11.45 | 6.10 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $497,216K ÷ $59,913K
= 8.30
TransMedics Group Inc's current ratio has displayed fluctuations over the period under review. The ratio stood at a healthy 6.10 as of March 31, 2020, indicating the company's ability to cover its short-term liabilities with its current assets. The ratio then showed a significant increase, reaching 11.45 by June 30, 2020, and remained relatively high in the subsequent periods, ranging from 11.31 to 12.36 by December 31, 2020.
However, towards the middle of 2021, the current ratio started to decline, dropping to 8.96 by June 30, 2021, and further decreasing to 5.11 by December 31, 2021. The ratio continued to decrease in the following quarters, hitting a low of 4.18 by June 30, 2022. This downward trend was a cause for concern as it indicated potential liquidity issues.
There was a notable improvement in the current ratio in the third quarter of 2022, jumping to 12.11, suggesting a better ability to cover short-term obligations with current assets. The ratio maintained a relatively strong position through the end of 2023, with values ranging from 9.14 to 9.72.
By the end of the review period on December 31, 2024, the current ratio stood at 8.30. Overall, while there were fluctuations in the current ratio over the years, TransMedics Group Inc generally demonstrated a solid ability to meet its short-term financial obligations during most periods, although there were instances of lower ratios that may have raised liquidity concerns.
Peer comparison
Dec 31, 2024